Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Health Canada has given approval to Scarguard Labs for selling Scarguard to physicians and consumers throughout Canada.
Subscribe to our email newsletter
Scarguard Labs is a pharmaceutical company specialising in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilising a multi-technology approach.
Scarguard Labs chairman and CEO Joel Studin said they are pleased to gain approval for retail in their first international market.
"Canadian market provides an opportunity for Scarguard to increase overall sales and profits by an estimated 15% while driving brand awareness with physicians as well as consumers," Studin said.